NDC00186-1033-91: BUPIVACAINE HYDROCHLORIDE INJECT.
BUPIVACAINE HYDROCHLORIDE INJECT. Key specifications include special_features: ALSO CONTAINS 8.000 MG SODIUM CHLORIDE PER ML, primary_container_type: VIAL, SINGLE DOSE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 30.000 MILLILITERS, active_medicament_medicinal_strength: 0.500 PERCENTAGE, W/V BUPIVACAINE HYDROCHLORIDE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: BUPIVACAINE HYDROCHLORIDE INJECTION USP 30ML VIAL 5S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-183-0242, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | ALSO CONTAINS 8.000 MG SODIUM CHLORIDE PER ML |
| primary_container_type | VIAL, SINGLE DOSE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 5 |
| primary_container_content_quantity | 30.000 MILLILITERS |
| active_medicament_medicinal_strength | 0.500 PERCENTAGE, W/V BUPIVACAINE HYDROCHLORIDE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | BUPIVACAINE HYDROCHLORIDE INJECTION USP 30ML VIAL 5S |
| NSN | 6505-01-183-0242 |
| PRIMARY CONTAINER CONTENT QUANTITY | 30.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
| SPECIAL FEATURES | ALSO CONTAINS 8.000 MG SODIUM CHLORIDE PER ML |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | BUPIVACAINE HYDROCHLORIDE INJECTION USP 30ML VIAL 5S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 0.500 PERCENTAGE, W/V BUPIVACAINE HYDROCHLORIDE ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 5 |